Crossmark

Adjuvant chemotherapy decision-making in stage II colon adenocarcinoma associated with patients’ age and high-risk factors

Crossref DOI link: https://doi.org/10.1007/s00384-023-04581-9

Published Online: 2023-12-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Pengwen https://orcid.org/0009-0000-4472-8528
Ye, Chao https://orcid.org/0009-0000-0651-2179
Liu, Hui https://orcid.org/0009-0002-9521-6586
Gao, Xinyi https://orcid.org/0000-0002-3678-1182
Huang, Hai https://orcid.org/0009-0004-2940-1614
Funding

Funding for this research was provided by:

Department of Education of Zhejiang Province (Y202248750)
License Information

Text and Data Mining valid from 2023-12-13

Version of Record valid from 2023-12-13
More Information

Article History

Accepted: 11 December 2023

First Online: 13 December 2023

Declarations

:

: The authors declare no competing interests.